KuangChi Science Limited announced that the Board announced that with effect from 8 May 2023 Dr. Deng Ke has resigned as an Independent Non-executive Director, a member of each of the Audit Committee, the Remuneration Committee and the Nomination Committee of the Company; and Dr. Wu Zhili has been appointed as an Independent Non-executive Director, a member of each of the Audit Committee, the Remuneration Committee and the Nomination Committee of the Company. Dr. Wu Zhili ("Dr. Wu"), aged 42, graduated from Hong Kong Baptist University in 2002, majoring in computer science and obtained a bachelor's degree. He has been studying in Hong Kong Baptist University thereafter and obtained a master's degree and a doctoral degree in 2004 and 2008, respectively.

Dr. Wu engaged in post-doctoral research at Hong Kong Baptist University from 2008 to 2009, while he engaged in post-doctoral research at the University of Leeds in the United Kingdom from 2009 to 2010. Dr. Wu has served as a senior researcher in Ericsson Research Institute and has worked as the chief AI officer and data officer in various companies. Afterwards, since 2017, Mr. Wu founded Shenzhen Yiyuan Intelligent Technology Co.

Ltd. . Yiyuan Intelligent focuses on the application of AI technology on the product development and expansion in the field of skin image segmentation and is actively expanding the feasibility of implementing AI-assisted dermatosis diagnosis and treatment in hospitals. In addition to serving as visiting professor and external hire lecturer, Dr. Wu has published numerous articles in relation to the artificial intelligence sector, with an aim to contribute to the technology and research of artificial intelligence.

By an appointment letter entered into with the Company on 8 May 2023, Dr. Wu shall serve as an Independent Non-executive Director for a term of three years but he will be subject to re-election at the next general meeting of the Company in accordance with the bye-laws of the Company. The director's fee payable to him is fixed at the rate of HKD 250,000 per annum, which was reviewed by the Remuneration Committee of the Company and determined by the Board with reference to his experience, duties and responsibilities in the Company as well as the current market rate. The Board further announces that following the resignation of Dr. Deng as a member of each of the Audit Committee, the Remuneration Committee and the Nomination Committee of the Company and Dr. Wu has been appointed as a member of each of the Audit Committee, the Remuneration Committee and the Nomination Committee of the Company with effect from 8 May 2023.